Adeno-Associated Viral Vector Manufacturing Market
According to a new market research report published by Global Market Estimates, the Global AdenoAssociated Viral Vector Manufacturing Market is projected to grow at a CAGR value of 22.9% from 2022 and 2027. Biomarin Pharmaceutical, Sarepta Therapeutics, Roche (Spark Therapeutics), Sangamo, Pfizer, NightstaRx, Freeline Therapeutics, Horama S.A, MeiraGTx, RegenxBio, Asklepios Biopharmaceutical, and Audentes Therapeutics, among others, are the key players in the adeno-associated viral vector manufacturing market.
Browse 151 Market Data Tables and 111 Figures spread through 181 Pages and in-depth TOC on “Global Adeno-Associated Viral Vector Manufacturing Market - Forecast to 2027” https://www.globalmarketestimates.com/market-report/adeno-associated-viral-vectormanufacturing-market-3736
By Type (Single-stranded AAV (ssAAV) and Self-complementary AAV (scAAV)), By Application (Hemophilia, Ophthalmology, Lysosomal Storage Disorders, Neurological Disorders, and Others), By Region (North America, Asia Pacific, CSA, Europe, and the Middle East and Africa); End-User Landscape, Company Market Share Analysis, and Competitor Analysis
Browse the Report @ https://www.globalmarketestimates.com/market-report/adeno-associated-viral-vectormanufacturing-market-3736
Type Outlook (Revenue, USD Million, 2022-2027)
Single-stranded AAV (ssAAV) Self-complementary AAV (scAAV)
Application Outlook (Revenue, USD Million, 2022-2027)
Hemophilia
Ophthalmology
Lysosomal Storage Disorders Neurological Disorders Others
Regional Outlook (Revenue, USD Million, 2022-2027) North America
The U.S.
Canada Mexico
Europe
Germany UK France Spain Italy
Rest of Europe
Asia Pacific
China India Japan South Korea Australia
Rest of APAC
Central & South America
Brazil Argentina Rest of CSA
Middle East & Africa
Saudi Arabia
UAE
Rest of MEA
Contact: Yash Jain Email address: yash.jain@globalmarketestimates.com Phone Number: +16026667238 Website: Global Market Estimates Check our Latest Blogs: https://www.globalmarketestimates.com/blog-posts.php